The rewarding properties of NMDA and MK-801 (dizocilpine) as indexed by the conditioned place preference paradigm

Pharmacology Biochemistry and Behavior

Volumn 64, Issue 3, 1999, Pages 591-595

  Panos, John J ^a   Rademacher, David J ^a   Renner, Staci L ^a   Steinpreis, Rhea E ^a  

^a UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

Conditioned place preference; Dizocilpine; MK 801; NMDA; Receptor antagonist; Reward mechanisms

Indexed keywords

DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG EFFECT; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REWARD;

ANIMALS; CONDITIONING, OPERANT; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; MALE; N-METHYLASPARTATE; RATS; RATS, SPRAGUE-DAWLEY; REWARD; SELF ADMINISTRATION;

EID: 0032857160     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(99)00155-0     Document Type: Article

References (43)

1. Acquas E., Carboni E., Leone P., Di Chiara G. SCH23390 blocks drug-conditioned place preference and place aversion. Anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade? Psychopharmacology (Berlin). 99:1989;151-155.
2. 3H] dopamine in the nucleus accumbens slices and its relationship with neocortical afferents. Prog. Neuropsychopharmacol. Biol. Psychiatry. 15:1991;663-676.
3. Bardo M.T., Neiswander J.L., Miller J.S. Repeated testing attenuates conditioned place preference with cocaine. Psychopharmacology (Berlin). 89:1996;239-242.
4. Barr G.A., Paredes W., Bridger W.H. Place conditioning with morphine and phencyclidine. Dose dependent effects Life Sci. 36:1985;363-368.
5. Beardsley P.M., Hayes B.A., Balster R.L. The self-administration of MK-801 can depend on drug-reinforcement history, and its discriminative stimulus properties are phencyclidine-like in rhesus monkeys. J. Pharmacol. Exp. Ther. 252:1990;953-959.
6. Beninger R.J. D-1 receptor involvement in reward related learning. J. Psychopharmacol. 6:1992;34-42.
7. Bespalov A., Dumpis M., Piotrovsky L., Zvartau E. Excitatory amino acid receptor antagonist kynurenic acid attenuates rewarding potential of morphine. Eur. J. Pharmacol. 264:1994;233-239.
8. Bilsky E.J., Marglin S.H., Reid L.D. Using antagonists to assess neurochemical coding of a drug's ability to establish a conditioned place preference. Pharmacol. Biochem. Behav. 37:1990;425-431.
9. Bonhaus D.W., McNamara J.O. N-Methyl-D-aspartate receptor regulation of uncompetitive antagonist binding in rat brain membranes. Kinetic analysis Mol. Pharmacol. 34:1988;250-255.
10. Carrozza D.P., Ferraro T.N., Golden G.T., Reyes P.F., Hare T. A. In vivo modulation of excitatory amino acid receptors. Microdialysis studies on N-methyl-D-aspartate-evoked striatal dopamine release and effects of antagonists Brain Res. 574:1992;42-48.
11. Chi O.Z., Chang Q, Weiss H.R. Effects of topical N-methyl-D-aspartate on blood-brain barrier permeability in the cerebral cortex of normotensive and hypertensive rats. Neurol. Res. 19:1997;539-544.
12. Clineschmidt B.V., Martin G.E., Bunting P.R. Central sympathomimetic activity of (±)-5-methyl-10, 11-dihydro-5H-dibenzo [a,d] cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties. Drug Dev. Res. 2:1982;134-145.
13. Del Pozo E., Barrios M., Baeyens J.M. The NMDA receptor antagonist dizocilpine (MK-801) stereoselectivity inhibits morphine-induced place preference conditioning in mice. Psychopharmacology (Berlin). 125:1996;209-213.
14. Ettenberg A. Dopamine, neuroleptics, and reinforced behavior. Neurosci. Behav. Rev. 13:1989;105-111.
15. Giménez-Llort L., Ferré S., Martinez E. Effects of the systemic administration of kainic acid and NMDA on exploratory activity in rats. Pharmacol. Biochem. Behav. 51:1995;205-210.
16. Giménez-Llort L., Martinez E., Camon L., de Vera N. Changes in brain putrescine concentration associated with nonconvulsant behavioral patterns induced by systemic N-methyl-D-aspartate injection. Mol. Chem. Neuropathol. 30:1997;289-302.
17. Hu X.T., White F.J. Electrophysiological analysis of excitatory amino acid receptor subtypes involved in glutamate-induced activation of rat nucleus neurons in vivo. Soc. Neurosci. Abstr. 20:1994;1635.
18. Hunter G.A., Reid L.D. Assaying the addiction liability of opioids. Life Sci. 33:1983;393-396.
19. Isaac W.L., Nonneman A.J., Neisewander J., Landers T., Bardo M.T. Prefrontal cortex lesions differentially disrupt cocaine-reinforced conditioned place preference but not conditioned taste aversion. Behav. Neurosci. 103:1989;345-355.
20. Johnson K.M., Jones S.M. Neuropharmacology of phencyclidine. Basic mechanisms and therapeutic potential Annu. Rev. Pharmacol. Toxicol. 30:1990;707-750.
21. Johnson S.W., Seutin V., North R.A. Burst firing in dopamine neurons induced by N-methyl-D-aspartate. Role of electrogenic sodium pump Science. 258:1992;665-667.
22. Kalivas P.W., Duffy P., Barrow J. Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes. J. Pharmacol. Exp. Ther. 251:1989;378-387.
23. Keppel G., Zedeck S. Data analysis for research designs. Analysis of variance and multiple regression/correlation approaches:1989;W. H. Freeman and Company, New York.
24. 3H] dibenzocycloalkenimine (MK-801) to the N-methyl-D-aspartate (NMDA) receptor and its therapeutic implications. FEBS Lett. 230:1988;167-170.
25. Layer R.T., Kaddis F.G., Wallace L.J. The NMDA receptor antagonist MK-801 elicits conditioned place preference in rats. Pharmacol. Biochem. Behav. 44:1993;245-247.
26. Lett B.T. Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacology (Berlin). 98:1989;357-362.
27. Löscher W., Annies R., Hönack D. The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats. Neurosci. Lett. 128:1991;191-194.
28. Marek P., Chapman C.D., Howard S. The effect of phencyclidine and DL-2-amino-5-phoshonvalic acid on N-Methyl-D-aspartic acid induced changes in extracellular concentration of dopamine and DOPAC in the rat neostriatum. Neuropharmacology. 31:1992;123-127.
29. Marglin S.H., Milano W.C., Mattie M.E., Reid L.D. PCP and conditioned place preference. Pharmacol. Biochem. Behav. 33:1988;281-283.
30. Martinez-Fong D., Rosales M.G., Gongora-Alfaro J.L., Hernandez S., Aceves J. NMDA receptor mediates dopamine release in the striatum of unanesthetized rats as measured by brain microdialysis. Brain Res. 595:1992;309-315.
31. Mithani S., Martin-Iverson M.T., Phillips A.G., Fibiger H.C. The effects of haloperidol on amphetamine- and methylphenidate-induced place preferences and locomotor activity. Psychopharmacology (Berlin). 90:1986;247-252.
32. Overton P., Clark D. Iontophoretically administered drugs acting at the N-methyl-D-aspartate receptor modulate burst firing in A9 dopamine neurons in the rat. Synapse. 10:1992;131-140.
33. Papp M., Moryl E., Maccecchini M.L. Differential effects of agents acting at various sites of the NMDA receptor complex in a place conditioning model. Eur. J. Pharmacol. 317:1996;191-196.
34. Rajdev S., Reynolds I.J. Effects of pH on the actions of dizocilpine at the N-methyl-D-aspartate receptor complex. Br. J. Pharmacol. 109:1993;107-112.
35. 3H] MK-801 binding to the NMDA receptor/ionophore complex is regulated by divalent cations. Evidence for multiple regulatory sites Eur. J. Pharmacol. 151:1988;103-112.
36. Schecter M.D. Effect of NMDA neurotoxicity upon its conditioned place preference and discrimination. Pharmacol. Biochem. Behav. 38:1991;539-544.
37. Starmer C.F., Packer D.L., Grant A.O. Ligand binding to transiently accessible sites. Mechanisms for varying apparent binding rates J. Theoret. Biol. 124:1987;335-341.
38. Steinpreis R.E., Kramer M.A., Mix K.S., Piwowarczyk M.C. The effects of MK-801 on place conditioning. Neurosci. Res. 22:1995;427-430.
39. Sukhotina I., Dravolina O., Bespalov A. Place conditioning of mice with the NMDA receptor antagonists, elipordil and dizocilpine. Eur. J. Pharmacol. 362:1998;103-110.
40. Svensson L., Zhang J., Johannessen K., Engel J.A. Effect of local infusion of glutamate analogues into the nucleus accumbens of rats. an electrochemical and behavioral study Brain Res. 643:1994;155-161.
41. Watkins J.C., Evans R.H. Excitatory amino acid transmitters. Annu. Rev. Pharmacol. Toxicol. 21:1981;165-204.
42. Westerink H.C., Enrico P., Feimann J., De Vries J.B. The pharmacology of mesocortical dopamine neurons. A dual-probe microdialysis study in the ventral tegmental area and prefrontal cortex of the rat brain J. Pharmacol. Exp. Ther. 285:1998;143-154.
43. Wise R.A. Neuroleptics and operant behavior. The anhedonia hypothesis Behav. Brain Res. 5:1983;39-53.